Photo of Rand Paul
R United States Senate · Kentucky

Sen. Rand Paul

Compare
Total votes
1,037
all sessions
Attendance
96%
40 missed
Near the chamber average
With party
75%
of cast votes
Lower than 100% of chamber peers
Bipartisan score
13%
some cross-party votes
Higher than 96% of chamber peers
Sponsored
488
bills & resolutions
Lower than 94% of chamber peers
Committees
13
assignments
488 bills and resolutions

Sponsored bills

Total
488
Primary
173
Co-sponsor
315
This page
488
matching current filters
Primary SCONRES 39
In committee · Delaware Senate · Lead sponsor
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2027 and setting forth the appropriate budgetary levels for fiscal years 2028 through 2036.

Maddy summaryThis concurrent resolution establishes the official budget framework for the U.S. federal government for fiscal year 2027 and sets spending targets for the subsequent nine years through 2036. It defines specific limits on total revenues, new budget authority, outlays, deficits, and public debt, while also allocating funds across major functional categories such as national defense, health care, and social security. The resolution directs various congressional committees to propose legislation that aligns with these targets, including a requirement for the Senate Finance Committee to identify at least $500 billion in deficit reduction over the ten-year period. Additionally, it grants budget committee chairs the authority to adjust allocations to accommodate emergency requirements, disaster relief, and changes in baseline estimates.

In committee Aug 7, 2026 0 co-sponsors
Primary S 2732
In committee · Delaware Senate · Lead sponsor
Bonuses for Cost-Cutters Act of 2025

Maddy summaryThe Bonuses for Cost-Cutters Act of 2025 creates a program to reward federal employees who identify unnecessary spending in agency budgets. Employees can report funds not required for agency operations (called "surplus salaries and expenses funds"), and agencies must verify these savings through their Inspector General or designated staff. If verified, agencies transfer the funds to the Treasury for deficit reduction, while retaining up to 10% of the amount to pay cash awards to the employees who identified the savings. Agencies must submit annual reports on savings and awards to the Treasury, which then shares this data with Congress. The program expires 6 years after enactment.

In committee Aug 6, 2026 0 co-sponsors
Primary S 2733
In committee · Delaware Senate · Lead sponsor
Duplication Scoring Act of 2025

Maddy summaryThe Duplication Scoring Act of 2025 requires the Government Accountability Office (GAO) to assess most federal bills and joint resolutions for risks of creating new redundant government programs or initiatives. For each covered bill, the GAO must identify if it would duplicate or overlap with existing programs previously flagged in GAO reports, specifying the program name, bill section, and relevant report. The GAO must publish this analysis online and provide it to Congress and the Congressional Budget Office (CBO), which may include the findings in its budget estimates. This bill directly affects congressional committees, the CBO, and federal agencies by adding a standardized duplication review step to the legislative process. It does not create new policies but mandates a new assessment mechanism for bills.

In committee Aug 6, 2026 0 co-sponsors
Primary S 5262
In committee · Delaware Senate · Lead sponsor
Defense of Environment and Property Act of 2026

Maddy summaryThe Defense of Environment and Property Act of 2026 significantly narrows the federal definition of "navigable waters" by excluding wetlands without continuous surface connections, intermittent streams, and groundwater from federal jurisdiction under the Clean Water Act. The bill prohibits federal agencies from using aggregation methods or the "significant nexus test" to assert authority over these excluded water bodies and invalidates existing regulations that expand the definition of covered waters. Additionally, it requires federal agencies to obtain written consent before entering private property for data collection and mandates that they pay affected landowners double the value of any economic loss caused by new federal water regulations.

In committee Aug 5, 2026 0 co-sponsors
Co-sponsor S 5206
In committee · Delaware Senate · Co-sponsor
Cold War Military Force Repeal Act

Maddy summaryThe Cold War Military Force Repeal Act removes an old 1958 law that authorized the President to use military force in the Middle East without a specific declaration of war. This legislation directly affects the legal framework governing U.S. military actions in the region by eliminating the authority granted under Public Law 85-7. By repealing this specific joint resolution, the bill clarifies that future military engagements in the Middle East must rely on current statutory or constitutional authorities rather than this historical mandate. The change does not create new powers or restrictions but simply deletes a provision from the United States Code that has been in place since the Cold War era.

In committee Jul 30, 2026 1 co-sponsor
Co-sponsor S 5185
In committee · Delaware Senate · Co-sponsor
Audit the Pentagon Act

Maddy summaryThe Audit the Pentagon Act requires the Department of Defense to reduce its funding by 2 percent if it fails to receive a clean financial audit for a given year. This penalty applies to all departments, agencies, and elements within the Pentagon starting after fiscal year 2024. The withheld money is distributed proportionally across various programs and projects, while the remaining funds are sent to the Treasury to help reduce the national deficit.

In committee Jul 30, 2026 1 co-sponsor
Co-sponsor S 5158
In committee · Delaware Senate · Co-sponsor
Federal Insurance Office Abolishment Act of 2026

Maddy summaryThe Federal Insurance Office Abolishment Act of 2026 eliminates the Federal Insurance Office within the Department of the Treasury and removes the position of its Director. This legislation amends existing laws to delete references to the office and its director, ensuring that related financial regulatory powers remain with the Secretary of the Treasury. By striking specific sections in the Dodd-Frank Act and other statutes, the bill clarifies that oversight of insurance matters will continue under the Treasury Secretary's authority without the dedicated office. The changes directly affect the organizational structure of federal financial regulation by removing a specific entity while preserving the underlying legal authority of the Treasury Department.

In committee Jul 29, 2026 1 co-sponsor
Co-sponsor S 1954
In committee · Delaware Senate · Co-sponsor
Biosimilar Red Tape Elimination Act

Maddy summaryThis bill simplifies the approval process for biosimilar drugs - medicines that are highly similar to, but not identical to, existing biologic drugs. It amends the Public Health Service Act to clarify when biosimilars are deemed "interchangeable" with the original drug (allowing pharmacists to substitute them without a doctor's specific order), adjusts exclusivity periods for existing biosimilars, and sets a 60-day transition period after enactment. The bill also requires the FDA to update its guidance documents within 18 months to reflect these changes. This directly affects pharmaceutical companies developing biosimilars, the FDA in its review process, and ultimately patients seeking more affordable treatment options.

In committee Jul 27, 2026 1 co-sponsor
Primary S 1414
In committee · Delaware Senate · Lead sponsor
Expedited Access to Biosimilars Act

Maddy summaryThis bill modifies requirements for approving biosimilar drugs (follow-on versions of biologic medicines). It removes previous mandatory assessments of immunogenicity or clinical efficacy for biosimilar licensure, instead allowing the FDA to require such studies only when the agency provides written justification to the applicant. The change applies to new biosimilar applications submitted after the bill's enactment. It directly affects drug manufacturers seeking FDA approval for biosimilars and the FDA's review process, aiming to streamline approvals while maintaining safety standards.

In committee Jul 27, 2026 0 co-sponsors
Co-sponsor SRES 801
Passed · Delaware Senate · Co-sponsor
A resolution honoring the life and legacy of the Honorable Lindsey Olin Graham, a Senator from the State of South Carolina.

Maddy summaryThis resolution honors the life and legacy of the late Senator Lindsey Olin Graham from South Carolina. It formally acknowledges his extensive career in the military, state government, and Congress, noting his service as a Senator and his roles as Chairman of the Judiciary and Budget committees. The Senate expresses its sorrow over his death and requests that this tribute be shared with the House of Representatives and Graham's family.

Passed Jul 16, 2026 1 co-sponsor
Showing 1 to 10 of 488 bills
1 2 3 49 Next